Total number of protein in "GO:0005216" GO term: 317
Identifier | UniProt Gene | UniProt Accession | UniProt Name | Chromosome | GO term | Database | Cancer Driver | Number of missense mutations | Missense mutation per residues | Number of disordered residues | Number of mutations in disordered regions | Disordered missense mutations per residues | Number of OMIM mutation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABCC8_ENST00000389817 | ABCC8 | Q09428 | ATP-binding cassette sub-family C member 8 | chr11 | GO:0005216 | Not Cancer Driver | No | 255 | 0.161 | 138 | 23 | 0.167 | 97 |
ABCC9_ENST00000261201 | ABCC9 | O60706 | ATP-binding cassette sub-family C member 9 | chr12 | GO:0005216 | Not Cancer Driver | No | 368 | 0.238 | 132 | 30 | 0.227 | 15 |
ANO1 | ANO1 | Q5XXA6 | Anoctamin-1 | chr11 | GO:0005216 | Not Cancer Driver | No | 155 | 0.157 | 168 | 14 | 0.083 | 0 |
ANO10 | ANO10 | Q9NW15 | Anoctamin-10 | chr3 | GO:0005216 | Not Cancer Driver | No | 65 | 0.098 | 18 | 2 | 0.111 | 1 |
ANO2_ENST00000327087 | ANO2 | Q9NQ90 | Anoctamin-2 | chr12 | GO:0005216 | Not Cancer Driver | No | 239 | 0.238 | 277 | 48 | 0.173 | 0 |
ANO3 | ANO3 | Q9BYT9 | Anoctamin-3 | chr11 | GO:0005216 | Not Cancer Driver | No | 197 | 0.201 | 102 | 20 | 0.196 | 4 |
ANO4 | ANO4 | Q32M45 | Anoctamin-4 | chr12 | GO:0005216 | Not Cancer Driver | No | 320 | 0.335 | 133 | 35 | 0.263 | 0 |
ANO5 | ANO5 | Q75V66 | Anoctamin-5 | chr11 | GO:0005216 | Not Cancer Driver | No | 227 | 0.249 | 42 | 17 | 0.405 | 3 |
ANO6_ENST00000320560 | ANO6 | Q4KMQ2 | Anoctamin-6 | chr12 | GO:0005216 | Not Cancer Driver | No | 134 | 0.147 | 80 | 11 | 0.138 | 0 |
ANO7 | ANO7 | Q6IWH7 | Anoctamin-7 | chr2 | GO:0005216 | Not Cancer Driver | No | 144 | 0.154 | 147 | 32 | 0.218 | 0 |
ANO8 | ANO8 | Q9HCE9 | Anoctamin-8 | chr19 | GO:0005216 | Not Cancer Driver | No | 105 | 0.085 | 606 | 44 | 0.073 | 0 |
ANO9 | ANO9 | A1A5B4 | Anoctamin-9 | chr11 | GO:0005216 | Not Cancer Driver | No | 108 | 0.138 | 64 | 6 | 0.094 | 0 |
AP000311.1 | AP000311.1 | H7C0C1 | ATP synthase subunit O, mitochondrial (Fragment) | chr21 | GO:0005216 | Not Cancer Driver | No | 27 | 0.112 | 27 | 5 | 0.185 | 0 |
AQP1 | AQP1 | P29972 | Aquaporin-1 | chr7 | GO:0005216 | Not Cancer Driver | No | 39 | 0.145 | 4 | 1 | 0.25 | 0 |
ASIC1_ENST00000447966 | ASIC1 | P78348 | Acid-sensing ion channel 1 | chr12 | GO:0005216 | Not Cancer Driver | No | 69 | 0.131 | 17 | 2 | 0.118 | 0 |
ASIC2_ENST00000359872 | ASIC2 | Q16515 | Acid-sensing ion channel 2 | chr17 | GO:0005216 | Not Cancer Driver | No | 101 | 0.197 | 49 | 1 | 0.02 | 0 |
ASIC3_ENST00000349064 | ASIC3 | Q9UHC3 | Acid-sensing ion channel 3 | chr7 | GO:0005216 | Not Cancer Driver | No | 83 | 0.156 | 126 | 23 | 0.183 | 0 |
ASIC5 | ASIC5 | Q9NY37 | Acid-sensing ion channel 5 | chr4 | GO:0005216 | Not Cancer Driver | No | 112 | 0.222 | 12 | 4 | 0.333 | 0 |
ATP5F1A_ENST00000282050 | ATP5F1A | P25705 | ATP synthase subunit alpha, mitochondrial | chr18 | GO:0005216 | Not Cancer Driver | No | 66 | 0.119 | 23 | 5 | 0.217 | 2 |
ATP5F1B | ATP5F1B | P06576 | ATP synthase subunit beta, mitochondrial | chr12 | GO:0005216 | Not Cancer Driver | No | 60 | 0.113 | 85 | 8 | 0.094 | 0 |
ATP5F1C | ATP5F1C | P36542 | ATP synthase subunit gamma, mitochondrial | chr10 | GO:0005216 | Not Cancer Driver | No | 39 | 0.131 | 11 | 0 | 0.0 | 0 |
ATP5F1D_ENST00000591660 | ATP5F1D | P30049 | ATP synthase subunit delta, mitochondrial | chr19 | GO:0005216 | Not Cancer Driver | No | 7 | 0.042 | 5 | 1 | 0.2 | 2 |
ATP5F1E_ENST00000395663 | ATP5F1E | P56381 | ATP synthase subunit epsilon, mitochondrial | chr20 | GO:0005216 | Not Cancer Driver | No | 3 | 0.059 | 1 | 0 | 0.0 | 1 |
ATP5ME | ATP5ME | P56385 | ATP synthase subunit e, mitochondrial | chr4 | GO:0005216 | Not Cancer Driver | No | 6 | 0.087 | 18 | 2 | 0.111 | 0 |
ATP5MF | ATP5MF | P56134 | ATP synthase subunit f, mitochondrial | chr7 | GO:0005216 | Not Cancer Driver | No | 22 | 0.234 | 0 | 0 | 0.0 | 0 |
ATP5MG | ATP5MG | O75964 | ATP synthase subunit g, mitochondrial | chr11 | GO:0005216 | Not Cancer Driver | No | 16 | 0.155 | 0 | 0 | 0.0 | 0 |
ATP5PB | ATP5PB | P24539 | ATP synthase F(0) complex subunit B1, mitochondrial | chr1 | GO:0005216 | Not Cancer Driver | No | 37 | 0.145 | 2 | 0 | 0.0 | 0 |
ATP5PD | ATP5PD | O75947 | ATP synthase subunit d, mitochondrial | chr17 | GO:0005216 | Not Cancer Driver | No | 12 | 0.075 | 15 | 0 | 0.0 | 0 |
ATP5PF_ENST00000400090 | ATP5PF | P18859 | ATP synthase-coupling factor 6, mitochondrial | chr21 | GO:0005216 | Not Cancer Driver | No | 14 | 0.13 | 15 | 1 | 0.067 | 0 |
ATP5PO | ATP5PO | P48047 | ATP synthase subunit O, mitochondrial | chr21 | GO:0005216 | Not Cancer Driver | No | 19 | 0.089 | 9 | 2 | 0.222 | 0 |
ATP6V0C | ATP6V0C | P27449 | V-type proton ATPase 16 kDa proteolipid subunit c | chr16 | GO:0005216 | Not Cancer Driver | No | 19 | 0.123 | 1 | 0 | 0.0 | 0 |
ATP6V1A | ATP6V1A | P38606 | V-type proton ATPase catalytic subunit A | chr3 | GO:0005216 | Not Cancer Driver | No | 86 | 0.139 | 31 | 2 | 0.065 | 4 |
BEST1_ENST00000378043 | BEST1 | O76090 | Bestrophin-1 | chr11 | GO:0005216 | Not Cancer Driver | No | 47 | 0.08 | 229 | 18 | 0.079 | 108 |
CACNA1A_ENST00000360228 | CACNA1A | O00555 | Voltage-dependent P/Q-type calcium channel subunit alpha-1A | chr19 | GO:0005216 | Not Cancer Driver | No | 436 | 0.174 | 1144 | 132 | 0.115 | 46 |
CACNA1B | CACNA1B | Q00975 | Voltage-dependent N-type calcium channel subunit alpha-1B | chr9 | GO:0005216 | Not Cancer Driver | No | 416 | 0.178 | 917 | 115 | 0.125 | 0 |
CACNA1C | CACNA1C | Q13936 | Voltage-dependent L-type calcium channel subunit alpha-1C | chr12 | GO:0005216 | Not Cancer Driver | No | 455 | 0.205 | 744 | 146 | 0.196 | 14 |
CACNA1D_ENST00000350061 | CACNA1D | Q01668 | Voltage-dependent L-type calcium channel subunit alpha-1D | chr3 | GO:0005216 | Census, Compendium | Yes | 342 | 0.158 | 736 | 126 | 0.171 | 2 |
CACNA1E_ENST00000621551 | CACNA1E | Q15878 | Voltage-dependent R-type calcium channel subunit alpha-1E | chr1 | GO:0005216 | Not Cancer Driver | No | 778 | 0.336 | 917 | 339 | 0.37 | 14 |
CACNA1F | CACNA1F | O60840 | Voltage-dependent L-type calcium channel subunit alpha-1F | chrX | GO:0005216 | Not Cancer Driver | No | 284 | 0.144 | 530 | 78 | 0.147 | 20 |
CACNA1G | CACNA1G | O43497 | Voltage-dependent T-type calcium channel subunit alpha-1G | chr17 | GO:0005216 | Not Cancer Driver | No | 367 | 0.154 | 1022 | 149 | 0.146 | 3 |
CACNA1H | CACNA1H | O95180 | Voltage-dependent T-type calcium channel subunit alpha-1H | chr16 | GO:0005216 | Not Cancer Driver | No | 323 | 0.137 | 1045 | 141 | 0.135 | 18 |
CACNA1I | CACNA1I | Q9P0X4 | Voltage-dependent T-type calcium channel subunit alpha-1I | chr22 | GO:0005216 | Not Cancer Driver | No | 272 | 0.122 | 870 | 73 | 0.084 | 0 |
CACNA1S | CACNA1S | Q13698 | Voltage-dependent L-type calcium channel subunit alpha-1S | chr1 | GO:0005216 | Not Cancer Driver | No | 389 | 0.208 | 382 | 76 | 0.199 | 6 |
CACNA2D1_ENST00000356253 | CACNA2D1 | P54289 | Voltage-dependent calcium channel subunit alpha-2/delta-1 | chr7 | GO:0005216 | Not Cancer Driver | No | 277 | 0.251 | 99 | 25 | 0.253 | 0 |
CACNB1 | CACNB1 | Q02641 | Voltage-dependent L-type calcium channel subunit beta-1 | chr17 | GO:0005216 | Not Cancer Driver | No | 75 | 0.125 | 396 | 47 | 0.119 | 0 |
CACNB2 | CACNB2 | Q08289 | Voltage-dependent L-type calcium channel subunit beta-2 | chr10 | GO:0005216 | Not Cancer Driver | No | 155 | 0.235 | 478 | 106 | 0.222 | 0 |
CACNB3 | CACNB3 | P54284 | Voltage-dependent L-type calcium channel subunit beta-3 | chr12 | GO:0005216 | Not Cancer Driver | No | 58 | 0.12 | 258 | 30 | 0.116 | 0 |
CACNB4 | CACNB4 | O00305 | Voltage-dependent L-type calcium channel subunit beta-4 | chr2 | GO:0005216 | Not Cancer Driver | No | 82 | 0.158 | 295 | 49 | 0.166 | 1 |
CCDC51 | CCDC51 | Q96ER9 | Mitochondrial potassium channel | chr3 | GO:0005216 | Not Cancer Driver | No | 51 | 0.124 | 137 | 21 | 0.153 | 0 |
CCT8L2 | CCT8L2 | Q96SF2 | T-complex protein 1 subunit theta-like 2 | chr22 | GO:0005216 | Not Cancer Driver | No | 216 | 0.388 | 104 | 46 | 0.442 | 0 |
CDK5 | CDK5 | Q00535 | Cyclin-dependent kinase 5 | chr7 | GO:0005216 | Not Cancer Driver | No | 48 | 0.164 | 5 | 1 | 0.2 | 0 |
CFTR | CFTR | P13569 | Cystic fibrosis transmembrane conductance regulator | chr7 | GO:0005216 | Not Cancer Driver | No | 287 | 0.194 | 145 | 18 | 0.124 | 151 |
CHRFAM7A | CHRFAM7A | Q494W8 | CHRNA7-FAM7A fusion protein | chr15 | GO:0005216 | Not Cancer Driver | No | 40 | 0.097 | 18 | 0 | 0.0 | 0 |
CHRNA10 | CHRNA10 | Q9GZZ6 | Neuronal acetylcholine receptor subunit alpha-10 | chr11 | GO:0005216 | Not Cancer Driver | No | 65 | 0.144 | 34 | 5 | 0.147 | 0 |
CHRNA1_ENST00000348749 | CHRNA1 | P02708 | Acetylcholine receptor subunit alpha | chr2 | GO:0005216 | Not Cancer Driver | No | 86 | 0.188 | 9 | 1 | 0.111 | 12 |
CHRNA2 | CHRNA2 | Q15822 | Neuronal acetylcholine receptor subunit alpha-2 | chr8 | GO:0005216 | Not Cancer Driver | No | 85 | 0.161 | 33 | 5 | 0.152 | 1 |
CHRNA3 | CHRNA3 | P32297 | Neuronal acetylcholine receptor subunit alpha-3 | chr15 | GO:0005216 | Not Cancer Driver | No | 86 | 0.17 | 11 | 1 | 0.091 | 0 |
CHRNA4 | CHRNA4 | P43681 | Neuronal acetylcholine receptor subunit alpha-4 | chr20 | GO:0005216 | Not Cancer Driver | No | 144 | 0.23 | 186 | 33 | 0.177 | 2 |
CHRNA5 | CHRNA5 | P30532 | Neuronal acetylcholine receptor subunit alpha-5 | chr15 | GO:0005216 | Not Cancer Driver | No | 63 | 0.135 | 24 | 3 | 0.125 | 0 |
CHRNA6 | CHRNA6 | Q15825 | Neuronal acetylcholine receptor subunit alpha-6 | chr8 | GO:0005216 | Not Cancer Driver | No | 101 | 0.204 | 33 | 6 | 0.182 | 0 |
CHRNA7_ENST00000306901 | CHRNA7 | P36544 | Neuronal acetylcholine receptor subunit alpha-7 | chr15 | GO:0005216 | Not Cancer Driver | No | 71 | 0.141 | 18 | 4 | 0.222 | 0 |
CHRNA9 | CHRNA9 | Q9UGM1 | Neuronal acetylcholine receptor subunit alpha-9 | chr4 | GO:0005216 | Not Cancer Driver | No | 76 | 0.159 | 23 | 6 | 0.261 | 0 |
CHRNB1 | CHRNB1 | P11230 | Acetylcholine receptor subunit beta | chr17 | GO:0005216 | Not Cancer Driver | No | 62 | 0.124 | 45 | 9 | 0.2 | 3 |
CHRNB2 | CHRNB2 | P17787 | Neuronal acetylcholine receptor subunit beta-2 | chr1 | GO:0005216 | Not Cancer Driver | No | 92 | 0.183 | 23 | 2 | 0.087 | 2 |
CHRNB3 | CHRNB3 | Q05901 | Neuronal acetylcholine receptor subunit beta-3 | chr8 | GO:0005216 | Not Cancer Driver | No | 125 | 0.273 | 4 | 1 | 0.25 | 0 |
CHRNB4 | CHRNB4 | P30926 | Neuronal acetylcholine receptor subunit beta-4 | chr15 | GO:0005216 | Not Cancer Driver | No | 98 | 0.197 | 30 | 6 | 0.2 | 0 |
CHRND | CHRND | Q07001 | Acetylcholine receptor subunit delta | chr2 | GO:0005216 | Not Cancer Driver | No | 110 | 0.213 | 71 | 19 | 0.268 | 7 |
CHRNE | CHRNE | Q04844 | Acetylcholine receptor subunit epsilon | chr17 | GO:0005216 | Not Cancer Driver | No | 52 | 0.105 | 37 | 3 | 0.081 | 13 |
CHRNG | CHRNG | P07510 | Acetylcholine receptor subunit gamma | chr2 | GO:0005216 | Not Cancer Driver | No | 78 | 0.151 | 8 | 1 | 0.125 | 4 |
CLCA1 | CLCA1 | A8K7I4 | Calcium-activated chloride channel regulator 1 | chr1 | GO:0005216 | Not Cancer Driver | No | 144 | 0.158 | 212 | 22 | 0.104 | 0 |
CLCA2 | CLCA2 | Q9UQC9 | Calcium-activated chloride channel regulator 2 | chr1 | GO:0005216 | Not Cancer Driver | No | 131 | 0.139 | 222 | 35 | 0.158 | 0 |
CLCA4 | CLCA4 | Q14CN2 | Calcium-activated chloride channel regulator 4 | chr1 | GO:0005216 | Not Cancer Driver | No | 191 | 0.208 | 192 | 41 | 0.214 | 0 |
CLCN1 | CLCN1 | P35523 | Chloride channel protein 1 | chr7 | GO:0005216 | Not Cancer Driver | No | 224 | 0.227 | 355 | 77 | 0.217 | 54 |
CLCN2 | CLCN2 | P51788 | Chloride channel protein 2 | chr3 | GO:0005216 | Not Cancer Driver | No | 124 | 0.138 | 224 | 38 | 0.17 | 8 |
CLCN3_ENST00000513761 | CLCN3 | P51790 | H(+)/Cl(-) exchange transporter 3 | chr4 | GO:0005216 | Not Cancer Driver | No | 105 | 0.128 | 88 | 7 | 0.08 | 0 |
CLCN4 | CLCN4 | P51793 | H(+)/Cl(-) exchange transporter 4 | chrX | GO:0005216 | Not Cancer Driver | No | 118 | 0.155 | 62 | 13 | 0.21 | 11 |
CLCN5 | CLCN5 | P51795 | H(+)/Cl(-) exchange transporter 5 | chrX | GO:0005216 | Not Cancer Driver | No | 138 | 0.169 | 81 | 6 | 0.074 | 32 |
CLCN6 | CLCN6 | P51797 | H(+)/Cl(-) exchange transporter 6 | chr1 | GO:0005216 | Not Cancer Driver | No | 123 | 0.142 | 109 | 24 | 0.22 | 1 |
CLCN7 | CLCN7 | P51798 | H(+)/Cl(-) exchange transporter 7 | chr16 | GO:0005216 | Not Cancer Driver | No | 102 | 0.127 | 94 | 7 | 0.074 | 29 |
CLCNKA | CLCNKA | P51800 | Chloride channel protein ClC-Ka | chr1 | GO:0005216 | Not Cancer Driver | No | 92 | 0.134 | 35 | 3 | 0.086 | 1 |
CLCNKB | CLCNKB | P51801 | Chloride channel protein ClC-Kb | chr1 | GO:0005216 | Not Cancer Driver | No | 104 | 0.151 | 23 | 9 | 0.391 | 5 |
CNGA1_ENST00000420489 | CNGA1 | P29973 | cGMP-gated cation channel alpha-1 | chr4 | GO:0005216 | Not Cancer Driver | No | 136 | 0.198 | 185 | 37 | 0.2 | 1 |
CNGA2 | CNGA2 | Q16280 | Cyclic nucleotide-gated olfactory channel | chrX | GO:0005216 | Not Cancer Driver | No | 159 | 0.239 | 161 | 33 | 0.205 | 0 |
CNGA3 | CNGA3 | Q16281 | Cyclic nucleotide-gated cation channel alpha-3 | chr2 | GO:0005216 | Not Cancer Driver | No | 183 | 0.264 | 217 | 67 | 0.309 | 53 |
CNGA4 | CNGA4 | Q8IV77 | Cyclic nucleotide-gated cation channel alpha-4 | chr11 | GO:0005216 | Not Cancer Driver | No | 132 | 0.23 | 79 | 13 | 0.165 | 0 |
CNGB1 | CNGB1 | Q14028 | Cyclic nucleotide-gated cation channel beta-1 | chr16 | GO:0005216 | Not Cancer Driver | No | 206 | 0.165 | 789 | 120 | 0.152 | 1 |
CNGB3 | CNGB3 | Q9NQW8 | Cyclic nucleotide-gated cation channel beta-3 | chr8 | GO:0005216 | Not Cancer Driver | No | 244 | 0.302 | 338 | 123 | 0.364 | 8 |
CNR1_ENST00000549890 | CNR1 | P21554 | Cannabinoid receptor 1 | chr6 | GO:0005216 | Not Cancer Driver | No | 129 | 0.273 | 9 | 1 | 0.111 | 0 |
FAM155A | NALF1 | B1AL88 | NALCN channel auxiliary factor 1 | chr13 | GO:0005216 | Not Cancer Driver | No | 121 | 0.264 | 162 | 51 | 0.315 | 0 |
FAM155B | NALF2 | O75949 | NALCN channel auxiliary factor 2 | chrX | GO:0005216 | Not Cancer Driver | No | 56 | 0.119 | 160 | 26 | 0.163 | 0 |
FKBP1B | FKBP1B | P68106 | Peptidyl-prolyl cis-trans isomerase FKBP1B | chr2 | GO:0005216 | Not Cancer Driver | No | 10 | 0.093 | 58 | 4 | 0.069 | 0 |
GABRA1_ENST00000638112 | GABRA1 | P14867 | Gamma-aminobutyric acid receptor subunit alpha-1 | chr5 | GO:0005216 | Not Cancer Driver | No | 175 | 0.384 | 58 | 31 | 0.534 | 6 |
GABRA2_ENST00000356504 | GABRA2 | P47869 | Gamma-aminobutyric acid receptor subunit alpha-2 | chr4 | GO:0005216 | Not Cancer Driver | No | 194 | 0.43 | 26 | 13 | 0.5 | 5 |
GABRA3_ENST00000535043 | GABRA3 | P34903 | Gamma-aminobutyric acid receptor subunit alpha-3 | chrX | GO:0005216 | Not Cancer Driver | No | 136 | 0.276 | 47 | 10 | 0.213 | 0 |
GABRA4 | GABRA4 | P48169 | Gamma-aminobutyric acid receptor subunit alpha-4 | chr4 | GO:0005216 | Not Cancer Driver | No | 191 | 0.345 | 179 | 82 | 0.458 | 0 |
GABRA5_ENST00000355395 | GABRA5 | P31644 | Gamma-aminobutyric acid receptor subunit alpha-5 | chr15 | GO:0005216 | Not Cancer Driver | No | 146 | 0.316 | 55 | 14 | 0.255 | 3 |
GABRA6 | GABRA6 | Q16445 | Gamma-aminobutyric acid receptor subunit alpha-6 | chr5 | GO:0005216 | Not Cancer Driver | No | 186 | 0.411 | 7 | 2 | 0.286 | 0 |
GABRB1 | GABRB1 | P18505 | Gamma-aminobutyric acid receptor subunit beta-1 | chr4 | GO:0005216 | Not Cancer Driver | No | 133 | 0.281 | 43 | 14 | 0.326 | 2 |
GABRB2_ENST00000393959 | GABRB2 | P47870 | Gamma-aminobutyric acid receptor subunit beta-2 | chr5 | GO:0005216 | Not Cancer Driver | No | 165 | 0.322 | 27 | 10 | 0.37 | 1 |
GABRB3 | GABRB3 | P28472 | Gamma-aminobutyric acid receptor subunit beta-3 | chr15 | GO:0005216 | Not Cancer Driver | No | 178 | 0.376 | 56 | 22 | 0.393 | 9 |
GABRD | GABRD | O14764 | Gamma-aminobutyric acid receptor subunit delta | chr1 | GO:0005216 | Not Cancer Driver | No | 71 | 0.157 | 19 | 5 | 0.263 | 1 |
GABRE | GABRE | P78334 | Gamma-aminobutyric acid receptor subunit epsilon | chrX | GO:0005216 | Not Cancer Driver | No | 133 | 0.263 | 73 | 19 | 0.26 | 0 |
GABRG1 | GABRG1 | Q8N1C3 | Gamma-aminobutyric acid receptor subunit gamma-1 | chr4 | GO:0005216 | Not Cancer Driver | No | 216 | 0.465 | 7 | 3 | 0.429 | 0 |
GABRG2_ENST00000639213 | GABRG2 | P18507 | Gamma-aminobutyric acid receptor subunit gamma-2 | chr5 | GO:0005216 | Not Cancer Driver | No | 188 | 0.403 | 19 | 13 | 0.684 | 11 |
GABRG3 | GABRG3 | Q99928 | Gamma-aminobutyric acid receptor subunit gamma-3 | chr15 | GO:0005216 | Not Cancer Driver | No | 137 | 0.293 | 12 | 5 | 0.417 | 0 |
GABRP_ENST00000265294 | GABRP | O00591 | Gamma-aminobutyric acid receptor subunit pi | chr5 | GO:0005216 | Not Cancer Driver | No | 81 | 0.184 | 0 | 0 | 0.0 | 0 |
GABRQ | GABRQ | Q9UN88 | Gamma-aminobutyric acid receptor subunit theta | chrX | GO:0005216 | Not Cancer Driver | No | 158 | 0.25 | 175 | 58 | 0.331 | 0 |
GABRR1 | GABRR1 | P24046 | Gamma-aminobutyric acid receptor subunit rho-1 | chr6 | GO:0005216 | Not Cancer Driver | No | 93 | 0.194 | 99 | 26 | 0.263 | 0 |
GABRR2 | GABRR2 | P28476 | Gamma-aminobutyric acid receptor subunit rho-2 | chr6 | GO:0005216 | Not Cancer Driver | No | 64 | 0.138 | 8 | 0 | 0.0 | 0 |
GABRR3 | GABRR3 | A8MPY1 | Gamma-aminobutyric acid receptor subunit rho-3 | chr3 | GO:0005216 | Not Cancer Driver | No | 76 | 0.163 | 30 | 7 | 0.233 | 0 |
GJC1_ENST00000590758 | GJC1 | P36383 | Gap junction gamma-1 protein | chr17 | GO:0005216 | Not Cancer Driver | No | 63 | 0.159 | 150 | 30 | 0.2 | 0 |
GJD3 | GJD3 | Q8N144 | Gap junction delta-3 protein | chr17 | GO:0005216 | Not Cancer Driver | No | 5 | 0.017 | 79 | 0 | 0.0 | 0 |
GLRA1 | GLRA1 | P23415 | Glycine receptor subunit alpha-1 | chr5 | GO:0005216 | Not Cancer Driver | No | 92 | 0.201 | 37 | 2 | 0.054 | 18 |
GLRA2 | GLRA2 | P23416 | Glycine receptor subunit alpha-2 | chrX | GO:0005216 | Not Cancer Driver | No | 106 | 0.235 | 58 | 14 | 0.241 | 0 |
GLRA3 | GLRA3 | O75311 | Glycine receptor subunit alpha-3 | chr4 | GO:0005216 | Not Cancer Driver | No | 132 | 0.284 | 32 | 11 | 0.344 | 0 |
GLRB | GLRB | P48167 | Glycine receptor subunit beta | chr4 | GO:0005216 | Not Cancer Driver | No | 112 | 0.225 | 66 | 12 | 0.182 | 4 |
GPR89A | GPR89A | B7ZAQ6 | Golgi pH regulator A | chr1 | GO:0005216 | Not Cancer Driver | No | 22 | 0.048 | 1 | 0 | 0.0 | 0 |
GPR89B | GPR89B | P0CG08 | Golgi pH regulator B | chr1 | GO:0005216 | Not Cancer Driver | No | 11 | 0.024 | 1 | 0 | 0.0 | 0 |
GRIA1_ENST00000285900 | GRIA1 | P42261 | Glutamate receptor 1 | chr5 | GO:0005216 | Not Cancer Driver | No | 303 | 0.334 | 104 | 45 | 0.433 | 0 |
GRIA2_ENST00000264426 | GRIA2 | P42262 | Glutamate receptor 2 | chr4 | GO:0005216 | Not Cancer Driver | No | 290 | 0.328 | 50 | 16 | 0.32 | 14 |
GRIA3 | GRIA3 | P42263 | Glutamate receptor 3 | chrX | GO:0005216 | Not Cancer Driver | No | 209 | 0.234 | 56 | 15 | 0.268 | 4 |
GRIA4_ENST00000530497 | GRIA4 | P48058 | Glutamate receptor 4 | chr11 | GO:0005216 | Not Cancer Driver | No | 227 | 0.252 | 63 | 25 | 0.397 | 4 |
GRID1 | GRID1 | Q9ULK0 | Glutamate receptor ionotropic, delta-1 | chr10 | GO:0005216 | Not Cancer Driver | No | 276 | 0.274 | 204 | 52 | 0.255 | 0 |
GRID2 | GRID2 | O43424 | Glutamate receptor ionotropic, delta-2 | chr4 | GO:0005216 | Not Cancer Driver | No | 350 | 0.348 | 155 | 35 | 0.226 | 3 |
GRIK1_ENST00000399907 | GRIK1 | P39086 | Glutamate receptor ionotropic, kainate 1 | chr21 | GO:0005216 | Not Cancer Driver | No | 196 | 0.214 | 50 | 5 | 0.1 | 0 |
GRIK2 | GRIK2 | Q13002 | Glutamate receptor ionotropic, kainate 2 | chr6 | GO:0005216 | Not Cancer Driver | No | 284 | 0.313 | 57 | 19 | 0.333 | 0 |
GRIK3 | GRIK3 | Q13003 | Glutamate receptor ionotropic, kainate 3 | chr1 | GO:0005216 | Not Cancer Driver | No | 256 | 0.279 | 38 | 9 | 0.237 | 0 |
GRIK4_ENST00000438375 | GRIK4 | Q16099 | Glutamate receptor ionotropic, kainate 4 | chr11 | GO:0005216 | Not Cancer Driver | No | 179 | 0.187 | 74 | 8 | 0.108 | 0 |
GRIK5_ENST00000593562 | GRIK5 | Q16478 | Glutamate receptor ionotropic, kainate 5 | chr19 | GO:0005216 | Not Cancer Driver | No | 176 | 0.18 | 135 | 9 | 0.067 | 0 |
GRIN1_ENST00000371561 | GRIN1 | Q05586 | Glutamate receptor ionotropic, NMDA 1 | chr9 | GO:0005216 | Not Cancer Driver | No | 88 | 0.094 | 190 | 15 | 0.079 | 13 |
GRIN2A_ENST00000330684 | GRIN2A | Q12879 | Glutamate receptor ionotropic, NMDA 2A | chr16 | GO:0005216 | Census, Compendium | Yes | 528 | 0.361 | 506 | 207 | 0.409 | 31 |
GRIN2B | GRIN2B | Q13224 | Glutamate receptor ionotropic, NMDA 2B | chr12 | GO:0005216 | Not Cancer Driver | No | 413 | 0.278 | 426 | 147 | 0.345 | 11 |
GRIN2C | GRIN2C | Q14957 | Glutamate receptor ionotropic, NMDA 2C | chr17 | GO:0005216 | Not Cancer Driver | No | 111 | 0.09 | 276 | 6 | 0.022 | 0 |
GRIN2D | GRIN2D | O15399 | Glutamate receptor ionotropic, NMDA 2D | chr19 | GO:0005216 | Not Cancer Driver | No | 125 | 0.094 | 467 | 15 | 0.032 | 1 |
GRIN3A | GRIN3A | Q8TCU5 | Glutamate receptor ionotropic, NMDA 3A | chr9 | GO:0005216 | Not Cancer Driver | No | 308 | 0.276 | 179 | 22 | 0.123 | 0 |
GRIN3B | GRIN3B | O60391 | Glutamate receptor ionotropic, NMDA 3B | chr19 | GO:0005216 | Not Cancer Driver | No | 90 | 0.086 | 299 | 23 | 0.077 | 0 |
HCN1 | HCN1 | O60741 | Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 | chr5 | GO:0005216 | Not Cancer Driver | No | 432 | 0.485 | 365 | 187 | 0.512 | 16 |
HCN2 | HCN2 | Q9UL51 | Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 | chr19 | GO:0005216 | Not Cancer Driver | No | 75 | 0.084 | 342 | 5 | 0.015 | 0 |
HCN3 | HCN3 | Q9P1Z3 | Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3 | chr1 | GO:0005216 | Not Cancer Driver | No | 107 | 0.138 | 260 | 22 | 0.085 | 0 |
HCN4 | HCN4 | Q9Y3Q4 | Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 | chr15 | GO:0005216 | Not Cancer Driver | No | 187 | 0.155 | 631 | 58 | 0.092 | 3 |
HTR1B | HTR1B | P28222 | 5-hydroxytryptamine receptor 1B | chr6 | GO:0005216 | Not Cancer Driver | No | 91 | 0.233 | 33 | 15 | 0.455 | 0 |
HTR3A_ENST00000504030 | HTR3A | P46098 | 5-hydroxytryptamine receptor 3A | chr11 | GO:0005216 | Not Cancer Driver | No | 127 | 0.266 | 45 | 13 | 0.289 | 0 |
HTR3B | HTR3B | O95264 | 5-hydroxytryptamine receptor 3B | chr11 | GO:0005216 | Not Cancer Driver | No | 91 | 0.206 | 8 | 0 | 0.0 | 0 |
HTR3C | HTR3C | Q8WXA8 | 5-hydroxytryptamine receptor 3C | chr3 | GO:0005216 | Not Cancer Driver | No | 82 | 0.183 | 35 | 7 | 0.2 | 0 |
HTR3D | HTR3D | Q70Z44 | 5-hydroxytryptamine receptor 3D | chr3 | GO:0005216 | Not Cancer Driver | No | 61 | 0.134 | 59 | 16 | 0.271 | 0 |
HTR3E_ENST00000415389 | HTR3E | A5X5Y0 | 5-hydroxytryptamine receptor 3E | chr3 | GO:0005216 | Not Cancer Driver | No | 87 | 0.191 | 56 | 18 | 0.321 | 0 |
HVCN1_ENST00000620084 | HVCN1 | Q96D96 | Voltage-gated hydrogen channel 1 | chr12 | GO:0005216 | Not Cancer Driver | No | 51 | 0.187 | 52 | 13 | 0.25 | 0 |
ITPR1_ENST00000354582 | ITPR1 | Q14643 | Inositol 1,4,5-trisphosphate receptor type 1 | chr3 | GO:0005216 | Not Cancer Driver | No | 390 | 0.141 | 581 | 76 | 0.131 | 6 |
ITPR2 | ITPR2 | Q14571 | Inositol 1,4,5-trisphosphate receptor type 2 | chr12 | GO:0005216 | Not Cancer Driver | No | 359 | 0.133 | 394 | 57 | 0.145 | 1 |
ITPR3 | ITPR3 | Q14573 | Inositol 1,4,5-trisphosphate receptor type 3 | chr6 | GO:0005216 | Not Cancer Driver | No | 336 | 0.126 | 385 | 44 | 0.114 | 0 |
KCNA10 | KCNA10 | Q16322 | Potassium voltage-gated channel subfamily A member 10 | chr1 | GO:0005216 | Not Cancer Driver | No | 118 | 0.231 | 110 | 30 | 0.273 | 0 |
KCNA2_ENST00000638616 | KCNA2 | P16389 | Potassium voltage-gated channel subfamily A member 2 | chr1 | GO:0005216 | Not Cancer Driver | No | 96 | 0.192 | 82 | 16 | 0.195 | 5 |
KCNA3 | KCNA3 | P22001 | Potassium voltage-gated channel subfamily A member 3 | chr1 | GO:0005216 | Not Cancer Driver | No | 120 | 0.209 | 169 | 16 | 0.095 | 0 |
KCNA5 | KCNA5 | P22460 | Potassium voltage-gated channel subfamily A member 5 | chr12 | GO:0005216 | Not Cancer Driver | No | 213 | 0.347 | 218 | 53 | 0.243 | 0 |
KCNB1_ENST00000635465 | KCNB1 | Q14721 | Potassium voltage-gated channel subfamily B member 1 | chr20 | GO:0005216 | Not Cancer Driver | No | 192 | 0.224 | 417 | 100 | 0.24 | 6 |
KCND1 | KCND1 | Q9NSA2 | Potassium voltage-gated channel subfamily D member 1 | chrX | GO:0005216 | Not Cancer Driver | No | 97 | 0.15 | 180 | 30 | 0.167 | 0 |
KCND2 | KCND2 | Q9NZV8 | Potassium voltage-gated channel subfamily D member 2 | chr7 | GO:0005216 | Not Cancer Driver | No | 220 | 0.349 | 195 | 62 | 0.318 | 0 |
KCND3 | KCND3 | Q9UK17 | Potassium voltage-gated channel subfamily D member 3 | chr1 | GO:0005216 | Not Cancer Driver | No | 172 | 0.263 | 202 | 44 | 0.218 | 5 |
KCNE1_ENST00000399284 | KCNE1 | P15382 | Potassium voltage-gated channel subfamily E member 1 | chr21 | GO:0005216 | Not Cancer Driver | No | 35 | 0.271 | 24 | 10 | 0.417 | 9 |
KCNE2 | KCNE2 | Q9Y6J6 | Potassium voltage-gated channel subfamily E member 2 | chr21 | GO:0005216 | Not Cancer Driver | No | 25 | 0.203 | 2 | 0 | 0.0 | 5 |
KCNE3 | KCNE3 | Q9Y6H6 | Potassium voltage-gated channel subfamily E member 3 | chr11 | GO:0005216 | Not Cancer Driver | No | 28 | 0.272 | 24 | 2 | 0.083 | 0 |
KCNE4 | KCNE4 | Q8WWG9 | Potassium voltage-gated channel subfamily E member 4 | chr2 | GO:0005216 | Not Cancer Driver | No | 26 | 0.118 | 94 | 18 | 0.191 | 0 |
KCNE5 | KCNE5 | Q9UJ90 | Potassium voltage-gated channel subfamily E regulatory beta subunit 5 | chrX | GO:0005216 | Not Cancer Driver | No | 35 | 0.246 | 68 | 26 | 0.382 | 0 |
KCNH2 | KCNH2 | Q12809 | Potassium voltage-gated channel subfamily H member 2 | chr7 | GO:0005216 | Not Cancer Driver | No | 189 | 0.163 | 466 | 50 | 0.107 | 117 |
KCNH6 | KCNH6 | Q9H252 | Potassium voltage-gated channel subfamily H member 6 | chr17 | GO:0005216 | Not Cancer Driver | No | 202 | 0.203 | 284 | 67 | 0.236 | 0 |
KCNH7 | KCNH7 | Q9NS40 | Potassium voltage-gated channel subfamily H member 7 | chr2 | GO:0005216 | Not Cancer Driver | No | 324 | 0.271 | 508 | 138 | 0.272 | 0 |
KCNIP2_ENST00000356640 | KCNIP2 | Q9NS61 | Kv channel-interacting protein 2 | chr10 | GO:0005216 | Not Cancer Driver | No | 34 | 0.126 | 89 | 16 | 0.18 | 0 |
KCNJ1 | KCNJ1 | P48048 | ATP-sensitive inward rectifier potassium channel 1 | chr11 | GO:0005216 | Not Cancer Driver | No | 83 | 0.212 | 10 | 0 | 0.0 | 13 |
KCNJ10 | KCNJ10 | P78508 | ATP-sensitive inward rectifier potassium channel 10 | chr1 | GO:0005216 | Not Cancer Driver | No | 78 | 0.206 | 28 | 10 | 0.357 | 8 |
KCNJ11 | KCNJ11 | Q14654 | ATP-sensitive inward rectifier potassium channel 11 | chr11 | GO:0005216 | Not Cancer Driver | No | 48 | 0.123 | 19 | 3 | 0.158 | 46 |
KCNJ12_ENST00000331718 | KCNJ12 | Q14500 | ATP-sensitive inward rectifier potassium channel 12 | chr17 | GO:0005216 | Not Cancer Driver | No | 248 | 0.573 | 50 | 27 | 0.54 | 0 |
KCNJ13_ENST00000410029 | KCNJ13 | O60928 | Inward rectifier potassium channel 13 | chr2 | GO:0005216 | Not Cancer Driver | No | 39 | 0.108 | 44 | 3 | 0.068 | 3 |
KCNJ14_ENST00000342291 | KCNJ14 | Q9UNX9 | ATP-sensitive inward rectifier potassium channel 14 | chr19 | GO:0005216 | Not Cancer Driver | No | 56 | 0.128 | 73 | 10 | 0.137 | 0 |
KCNJ15_ENST00000398934 | KCNJ15 | Q99712 | ATP-sensitive inward rectifier potassium channel 15 | chr21 | GO:0005216 | Not Cancer Driver | No | 85 | 0.227 | 12 | 2 | 0.167 | 0 |
KCNJ16_ENST00000283936 | KCNJ16 | Q9NPI9 | Inward rectifier potassium channel 16 | chr17 | GO:0005216 | Not Cancer Driver | No | 88 | 0.211 | 38 | 8 | 0.211 | 5 |
KCNJ2_ENST00000535240 | KCNJ2 | P63252 | Inward rectifier potassium channel 2 | chr17 | GO:0005216 | Not Cancer Driver | No | 103 | 0.241 | 49 | 11 | 0.224 | 12 |
KCNJ3 | KCNJ3 | P48549 | G protein-activated inward rectifier potassium channel 1 | chr2 | GO:0005216 | Not Cancer Driver | No | 189 | 0.377 | 162 | 64 | 0.395 | 0 |
KCNJ4 | KCNJ4 | P48050 | Inward rectifier potassium channel 4 | chr22 | GO:0005216 | Not Cancer Driver | No | 103 | 0.231 | 62 | 16 | 0.258 | 0 |
KCNJ5_ENST00000533599 | KCNJ5 | P48544 | G protein-activated inward rectifier potassium channel 4 | chr11 | GO:0005216 | Census | Yes | 87 | 0.208 | 51 | 6 | 0.118 | 6 |
KCNJ6_ENST00000645093 | KCNJ6 | P48051 | G protein-activated inward rectifier potassium channel 2 | chr21 | GO:0005216 | Not Cancer Driver | No | 106 | 0.251 | 75 | 13 | 0.173 | 1 |
KCNJ8 | KCNJ8 | Q15842 | ATP-sensitive inward rectifier potassium channel 8 | chr12 | GO:0005216 | Not Cancer Driver | No | 99 | 0.233 | 68 | 22 | 0.324 | 1 |
KCNJ9 | KCNJ9 | Q92806 | G protein-activated inward rectifier potassium channel 3 | chr1 | GO:0005216 | Not Cancer Driver | No | 47 | 0.12 | 67 | 1 | 0.015 | 0 |
KCNK1 | KCNK1 | O00180 | Potassium channel subfamily K member 1 | chr1 | GO:0005216 | Not Cancer Driver | No | 65 | 0.193 | 21 | 4 | 0.19 | 0 |
KCNK10_ENST00000340700 | KCNK10 | P57789 | Potassium channel subfamily K member 10 | chr14 | GO:0005216 | Not Cancer Driver | No | 138 | 0.257 | 174 | 47 | 0.27 | 0 |
KCNK12 | KCNK12 | Q9HB15 | Potassium channel subfamily K member 12 | chr2 | GO:0005216 | Not Cancer Driver | No | 6 | 0.014 | 29 | 0 | 0.0 | 0 |
KCNK13 | KCNK13 | Q9HB14 | Potassium channel subfamily K member 13 | chr14 | GO:0005216 | Not Cancer Driver | No | 99 | 0.243 | 32 | 8 | 0.25 | 0 |
KCNK15 | KCNK15 | Q9H427 | Potassium channel subfamily K member 15 | chr20 | GO:0005216 | Not Cancer Driver | No | 54 | 0.164 | 32 | 8 | 0.25 | 0 |
KCNK16_ENST00000373229 | KCNK16 | Q96T55 | Potassium channel subfamily K member 16 | chr6 | GO:0005216 | Not Cancer Driver | No | 63 | 0.204 | 14 | 1 | 0.071 | 0 |
KCNK17 | KCNK17 | Q96T54 | Potassium channel subfamily K member 17 | chr6 | GO:0005216 | Not Cancer Driver | No | 46 | 0.139 | 31 | 11 | 0.355 | 0 |
KCNK18 | KCNK18 | Q7Z418 | Potassium channel subfamily K member 18 | chr10 | GO:0005216 | Not Cancer Driver | No | 103 | 0.268 | 7 | 0 | 0.0 | 0 |
KCNK2 | KCNK2 | O95069 | Potassium channel subfamily K member 2 | chr1 | GO:0005216 | Not Cancer Driver | No | 109 | 0.256 | 40 | 10 | 0.25 | 0 |
KCNK3 | KCNK3 | O14649 | Potassium channel subfamily K member 3 | chr2 | GO:0005216 | Not Cancer Driver | No | 54 | 0.137 | 60 | 7 | 0.117 | 6 |
KCNK4 | KCNK4 | Q9NYG8 | Potassium channel subfamily K member 4 | chr11 | GO:0005216 | Not Cancer Driver | No | 34 | 0.087 | 142 | 7 | 0.049 | 2 |
KCNK5 | KCNK5 | O95279 | Potassium channel subfamily K member 5 | chr6 | GO:0005216 | Not Cancer Driver | No | 94 | 0.188 | 206 | 36 | 0.175 | 0 |
KCNK6 | KCNK6 | Q9Y257 | Potassium channel subfamily K member 6 | chr19 | GO:0005216 | Not Cancer Driver | No | 39 | 0.125 | 22 | 4 | 0.182 | 0 |
KCNK7 | KCNK7 | Q9Y2U2 | Potassium channel subfamily K member 7 | chr11 | GO:0005216 | Not Cancer Driver | No | 31 | 0.101 | 6 | 1 | 0.167 | 0 |
KCNK9 | KCNK9 | Q9NPC2 | Potassium channel subfamily K member 9 | chr8 | GO:0005216 | Not Cancer Driver | No | 139 | 0.372 | 58 | 22 | 0.379 | 2 |
KCNMA1 | KCNMA1 | Q12791 | Calcium-activated potassium channel subunit alpha-1 | chr10 | GO:0005216 | Not Cancer Driver | No | 222 | 0.18 | 225 | 39 | 0.173 | 5 |
KCNN1 | KCNN1 | Q92952 | Small conductance calcium-activated potassium channel protein 1 | chr19 | GO:0005216 | Not Cancer Driver | No | 83 | 0.153 | 192 | 19 | 0.099 | 0 |
KCNN2 | KCNN2 | Q9H2S1 | Small conductance calcium-activated potassium channel protein 2 | chr5 | GO:0005216 | Not Cancer Driver | No | 112 | 0.193 | 175 | 33 | 0.189 | 0 |
KCNN3_ENST00000271915 | KCNN3 | Q9UGI6 | Small conductance calcium-activated potassium channel protein 3 | chr1 | GO:0005216 | Not Cancer Driver | No | 135 | 0.185 | 302 | 56 | 0.185 | 3 |
KCNN4 | KCNN4 | O15554 | Intermediate conductance calcium-activated potassium channel protein 4 | chr19 | GO:0005216 | Not Cancer Driver | No | 60 | 0.141 | 31 | 6 | 0.194 | 3 |
KCNQ1 | KCNQ1 | P51787 | Potassium voltage-gated channel subfamily KQT member 1 | chr11 | GO:0005216 | Not Cancer Driver | No | 78 | 0.115 | 219 | 20 | 0.091 | 132 |
KCNT1_ENST00000488444 | KCNT1 | Q5JUK3 | Potassium channel subfamily T member 1 | chr9 | GO:0005216 | Not Cancer Driver | No | 187 | 0.152 | 328 | 31 | 0.095 | 12 |
KCNT2 | KCNT2 | Q6UVM3 | Potassium channel subfamily T member 2 | chr1 | GO:0005216 | Not Cancer Driver | No | 353 | 0.311 | 245 | 89 | 0.363 | 1 |
KCNU1 | KCNU1 | A8MYU2 | Potassium channel subfamily U member 1 | chr8 | GO:0005216 | Not Cancer Driver | No | 279 | 0.243 | 140 | 40 | 0.286 | 0 |
LRRC8A_ENST00000372599 | LRRC8A | Q8IWT6 | Volume-regulated anion channel subunit LRRC8A | chr9 | GO:0005216 | Not Cancer Driver | No | 105 | 0.13 | 32 | 3 | 0.094 | 0 |
LRRC8B | LRRC8B | Q6P9F7 | Volume-regulated anion channel subunit LRRC8B | chr1 | GO:0005216 | Not Cancer Driver | No | 82 | 0.102 | 0 | 0 | 0.0 | 0 |
LRRC8C | LRRC8C | Q8TDW0 | Volume-regulated anion channel subunit LRRC8C | chr1 | GO:0005216 | Not Cancer Driver | No | 93 | 0.116 | 59 | 6 | 0.102 | 0 |
LRRC8D | LRRC8D | Q7L1W4 | Volume-regulated anion channel subunit LRRC8D | chr1 | GO:0005216 | Not Cancer Driver | No | 99 | 0.115 | 98 | 18 | 0.184 | 0 |
LRRC8E | LRRC8E | Q6NSJ5 | Volume-regulated anion channel subunit LRRC8E | chr19 | GO:0005216 | Not Cancer Driver | No | 77 | 0.097 | 35 | 0 | 0.0 | 0 |
MCOLN1 | MCOLN1 | Q9GZU1 | Mucolipin-1 | chr19 | GO:0005216 | Not Cancer Driver | No | 77 | 0.133 | 63 | 15 | 0.238 | 7 |
MCOLN2 | MCOLN2 | Q8IZK6 | Mucolipin-2 | chr1 | GO:0005216 | Not Cancer Driver | No | 93 | 0.164 | 0 | 0 | 0.0 | 0 |
MCOLN3 | MCOLN3 | Q8TDD5 | Mucolipin-3 | chr1 | GO:0005216 | Not Cancer Driver | No | 102 | 0.184 | 9 | 2 | 0.222 | 0 |
MCUB | MCUB | Q9NWR8 | Calcium uniporter regulatory subunit MCUb, mitochondrial | chr4 | GO:0005216 | Not Cancer Driver | No | 33 | 0.098 | 24 | 1 | 0.042 | 0 |
NALCN | NALCN | Q8IZF0 | Sodium leak channel NALCN | chr13 | GO:0005216 | Not Cancer Driver | No | 499 | 0.287 | 260 | 74 | 0.285 | 11 |
NMUR2 | NMUR2 | Q9GZQ4 | Neuromedin-U receptor 2 | chr5 | GO:0005216 | Not Cancer Driver | No | 139 | 0.335 | 5 | 1 | 0.2 | 0 |
NOX5 | NOX5 | Q96PH1 | NADPH oxidase 5 | chr15 | GO:0005216 | Not Cancer Driver | No | 118 | 0.154 | 95 | 9 | 0.095 | 0 |
ORAI1 | ORAI1 | Q96D31 | Calcium release-activated calcium channel protein 1 | chr12 | GO:0005216 | Not Cancer Driver | No | 26 | 0.086 | 101 | 9 | 0.089 | 5 |
ORAI2 | ORAI2 | Q96SN7 | Protein orai-2 | chr7 | GO:0005216 | Not Cancer Driver | No | 34 | 0.134 | 23 | 3 | 0.13 | 0 |
ORAI3 | ORAI3 | Q9BRQ5 | Protein orai-3 | chr16 | GO:0005216 | Not Cancer Driver | No | 31 | 0.105 | 93 | 12 | 0.129 | 0 |
OTOP1 | OTOP1 | Q7RTM1 | Proton channel OTOP1 | chr4 | GO:0005216 | Not Cancer Driver | No | 104 | 0.17 | 89 | 11 | 0.124 | 0 |
OTOP2 | OTOP2 | Q7RTS6 | Proton channel OTOP2 | chr17 | GO:0005216 | Not Cancer Driver | No | 79 | 0.141 | 48 | 11 | 0.229 | 0 |
OTOP3 | OTOP3 | Q7RTS5 | Proton channel OTOP3 | chr17 | GO:0005216 | Not Cancer Driver | No | 95 | 0.159 | 68 | 6 | 0.088 | 0 |
P2RX1 | P2RX1 | P51575 | P2X purinoceptor 1 | chr17 | GO:0005216 | Not Cancer Driver | No | 59 | 0.148 | 14 | 1 | 0.071 | 0 |
P2RX2_ENST00000643471 | P2RX2 | Q9UBL9 | P2X purinoceptor 2 | chr12 | GO:0005216 | Not Cancer Driver | No | 62 | 0.132 | 104 | 13 | 0.125 | 2 |
P2RX3 | P2RX3 | P56373 | P2X purinoceptor 3 | chr11 | GO:0005216 | Not Cancer Driver | No | 85 | 0.214 | 15 | 6 | 0.4 | 0 |
P2RX4_ENST00000337233 | P2RX4 | Q99571 | P2X purinoceptor 4 | chr12 | GO:0005216 | Not Cancer Driver | No | 36 | 0.093 | 0 | 0 | 0.0 | 0 |
P2RX5 | P2RX5 | Q93086 | P2X purinoceptor 5 | chr17 | GO:0005216 | Not Cancer Driver | No | 58 | 0.137 | 73 | 14 | 0.192 | 0 |
P2RX6 | P2RX6 | O15547 | P2X purinoceptor 6 | chr22 | GO:0005216 | Not Cancer Driver | No | 33 | 0.075 | 43 | 1 | 0.023 | 0 |
P2RX7 | P2RX7 | Q99572 | P2X purinoceptor 7 | chr12 | GO:0005216 | Not Cancer Driver | No | 51 | 0.086 | 14 | 2 | 0.143 | 0 |
PEX5L | PEX5L | Q8IYB4 | PEX5-related protein | chr3 | GO:0005216 | Not Cancer Driver | No | 152 | 0.243 | 346 | 103 | 0.298 | 0 |
PIEZO1 | PIEZO1 | Q92508 | Piezo-type mechanosensitive ion channel component 1 | chr16 | GO:0005216 | Not Cancer Driver | No | 122 | 0.048 | 471 | 26 | 0.055 | 12 |
PIEZO2 | PIEZO2 | Q9H5I5 | Piezo-type mechanosensitive ion channel component 2 | chr18 | GO:0005216 | Not Cancer Driver | No | 198 | 0.072 | 603 | 19 | 0.032 | 8 |
PKD2 | PKD2 | Q13563 | Polycystin-2 | chr4 | GO:0005216 | Not Cancer Driver | No | 113 | 0.117 | 375 | 35 | 0.093 | 10 |
PTK2B_ENST00000346049 | PTK2B | Q14289 | Protein-tyrosine kinase 2-beta | chr8 | GO:0005216 | Not Cancer Driver | No | 161 | 0.16 | 261 | 37 | 0.142 | 0 |
RASA3 | RASA3 | Q14644 | Ras GTPase-activating protein 3 | chr13 | GO:0005216 | Not Cancer Driver | No | 118 | 0.141 | 101 | 19 | 0.188 | 0 |
RHAG | RHAG | Q02094 | Ammonium transporter Rh type A | chr6 | GO:0005216 | Not Cancer Driver | No | 102 | 0.249 | 0 | 0 | 0.0 | 6 |
RHBG | RHBG | Q9H310 | Ammonium transporter Rh type B | chr1 | GO:0005216 | Not Cancer Driver | No | 66 | 0.144 | 32 | 7 | 0.219 | 0 |
RHCE | RHCE | P18577 | Blood group Rh(CE) polypeptide | chr1 | GO:0005216 | Not Cancer Driver | No | 64 | 0.153 | 8 | 5 | 0.625 | 0 |
RHCG | RHCG | Q9UBD6 | Ammonium transporter Rh type C | chr15 | GO:0005216 | Not Cancer Driver | No | 74 | 0.154 | 19 | 2 | 0.105 | 0 |
RHD_ENST00000328664 | RHD | Q02161 | Blood group Rh(D) polypeptide | chr1 | GO:0005216 | Not Cancer Driver | No | 55 | 0.132 | 9 | 0 | 0.0 | 0 |
RYR1 | RYR1 | P21817 | Ryanodine receptor 1 | chr19 | GO:0005216 | Not Cancer Driver | No | 1003 | 0.199 | 1186 | 233 | 0.196 | 154 |
RYR2 | RYR2 | Q92736 | Ryanodine receptor 2 | chr1 | GO:0005216 | Not Cancer Driver | No | 1703 | 0.343 | 782 | 281 | 0.359 | 51 |
RYR3 | RYR3 | Q15413 | Ryanodine receptor 3 | chr15 | GO:0005216 | Not Cancer Driver | No | 1079 | 0.222 | 649 | 162 | 0.25 | 0 |
SCN10A | SCN10A | Q9Y5Y9 | Sodium channel protein type 10 subunit alpha | chr3 | GO:0005216 | Not Cancer Driver | No | 513 | 0.262 | 435 | 131 | 0.301 | 2 |
SCN11A | SCN11A | Q9UI33 | Sodium channel protein type 11 subunit alpha | chr3 | GO:0005216 | Not Cancer Driver | No | 475 | 0.265 | 198 | 61 | 0.308 | 9 |
SCN1A_ENST00000423058 | SCN1A | P35498 | Sodium channel protein type 1 subunit alpha | chr2 | GO:0005216 | Not Cancer Driver | No | 497 | 0.247 | 455 | 121 | 0.266 | 396 |
SCN1B_ENST00000262631 | SCN1B | Q07699 | Sodium channel subunit beta-1 | chr19 | GO:0005216 | Not Cancer Driver | No | 35 | 0.161 | 4 | 1 | 0.25 | 5 |
SCN2A_ENST00000637266 | SCN2A | Q99250 | Sodium channel protein type 2 subunit alpha | chr2 | GO:0005216 | Not Cancer Driver | No | 502 | 0.25 | 435 | 133 | 0.306 | 65 |
SCN2B | SCN2B | O60939 | Sodium channel subunit beta-2 | chr11 | GO:0005216 | Not Cancer Driver | No | 46 | 0.214 | 52 | 7 | 0.135 | 2 |
SCN3A_ENST00000360093 | SCN3A | Q9NY46 | Sodium channel protein type 3 subunit alpha | chr2 | GO:0005216 | Not Cancer Driver | No | 415 | 0.207 | 432 | 83 | 0.192 | 6 |
SCN3B_ENST00000299333 | SCN3B | Q9NY72 | Sodium channel subunit beta-3 | chr11 | GO:0005216 | Not Cancer Driver | No | 63 | 0.293 | 16 | 5 | 0.312 | 3 |
SCN4A | SCN4A | P35499 | Sodium channel protein type 4 subunit alpha | chr17 | GO:0005216 | Not Cancer Driver | No | 324 | 0.176 | 372 | 80 | 0.215 | 60 |
SCN4B | SCN4B | Q8IWT1 | Sodium channel subunit beta-4 | chr11 | GO:0005216 | Not Cancer Driver | No | 23 | 0.101 | 46 | 4 | 0.087 | 3 |
SCN5A_ENST00000333535 | SCN5A | Q14524 | Sodium channel protein type 5 subunit alpha | chr3 | GO:0005216 | Not Cancer Driver | No | 491 | 0.244 | 550 | 144 | 0.262 | 190 |
SCN7A_ENST00000409855 | SCN7A | Q01118 | Sodium channel protein type 7 subunit alpha | chr2 | GO:0005216 | Not Cancer Driver | No | 395 | 0.235 | 171 | 43 | 0.251 | 0 |
SCN8A | SCN8A | Q9UQD0 | Sodium channel protein type 8 subunit alpha | chr12 | GO:0005216 | Not Cancer Driver | No | 290 | 0.146 | 460 | 75 | 0.163 | 28 |
SCN9A_ENST00000642356 | SCN9A | Q15858 | Sodium channel protein type 9 subunit alpha | chr2 | GO:0005216 | Not Cancer Driver | No | 461 | 0.232 | 490 | 126 | 0.257 | 21 |
SCNN1A_ENST00000228916 | SCNN1A | P37088 | Amiloride-sensitive sodium channel subunit alpha | chr12 | GO:0005216 | Not Cancer Driver | No | 73 | 0.109 | 146 | 21 | 0.144 | 5 |
SCNN1B | SCNN1B | P51168 | Amiloride-sensitive sodium channel subunit beta | chr16 | GO:0005216 | Not Cancer Driver | No | 90 | 0.141 | 62 | 4 | 0.065 | 13 |
SCNN1D | SCNN1D | P51172 | Amiloride-sensitive sodium channel subunit delta | chr1 | GO:0005216 | Not Cancer Driver | No | 56 | 0.07 | 210 | 9 | 0.043 | 0 |
SCNN1G | SCNN1G | P51170 | Amiloride-sensitive sodium channel subunit gamma | chr16 | GO:0005216 | Not Cancer Driver | No | 129 | 0.199 | 57 | 11 | 0.193 | 0 |
SHROOM2 | SHROOM2 | Q13796 | Protein Shroom2 | chrX | GO:0005216 | Not Cancer Driver | No | 215 | 0.133 | 1381 | 188 | 0.136 | 0 |
SLC12A2 | SLC12A2 | P55011 | Solute carrier family 12 member 2 | chr5 | GO:0005216 | Not Cancer Driver | No | 141 | 0.116 | 297 | 18 | 0.061 | 8 |
SLC12A4_ENST00000316341 | SLC12A4 | Q9UP95 | Solute carrier family 12 member 4 | chr16 | GO:0005216 | Not Cancer Driver | No | 122 | 0.112 | 171 | 17 | 0.099 | 0 |
SLC12A5 | SLC12A5 | Q9H2X9 | Solute carrier family 12 member 5 | chr20 | GO:0005216 | Not Cancer Driver | No | 263 | 0.231 | 290 | 59 | 0.203 | 5 |
SLC12A6_ENST00000558667 | SLC12A6 | Q9UHW9 | Solute carrier family 12 member 6 | chr15 | GO:0005216 | Not Cancer Driver | No | 168 | 0.146 | 280 | 46 | 0.164 | 0 |
SLC12A7 | SLC12A7 | Q9Y666 | Solute carrier family 12 member 7 | chr5 | GO:0005216 | Not Cancer Driver | No | 153 | 0.141 | 202 | 23 | 0.114 | 0 |
SLC17A3_ENST00000360657 | SLC17A3 | O00476 | Sodium-dependent phosphate transport protein 4 | chr6 | GO:0005216 | Not Cancer Driver | No | 97 | 0.231 | 26 | 6 | 0.231 | 0 |
SLC1A1 | SLC1A1 | P43005 | Excitatory amino acid transporter 3 | chr9 | GO:0005216 | Not Cancer Driver | No | 69 | 0.132 | 17 | 4 | 0.235 | 1 |
SLC4A11_ENST00000539553 | SLC4A11 | Q8NBS3 | Solute carrier family 4 member 11 | chr20 | GO:0005216 | Not Cancer Driver | No | 159 | 0.182 | 69 | 10 | 0.145 | 42 |
SLC9C1 | SLC9C1 | Q4G0N8 | Sodium/hydrogen exchanger 10 | chr3 | GO:0005216 | Not Cancer Driver | No | 214 | 0.182 | 44 | 9 | 0.205 | 0 |
STIM2_ENST00000467087 | STIM2 | Q9P246 | Stromal interaction molecule 2 | chr4 | GO:0005216 | Not Cancer Driver | No | 82 | 0.11 | 387 | 45 | 0.116 | 0 |
TMC1 | TMC1 | Q8TDI8 | Transmembrane channel-like protein 1 | chr9 | GO:0005216 | Not Cancer Driver | No | 121 | 0.159 | 97 | 10 | 0.103 | 2 |
TMC2 | TMC2 | Q8TDI7 | Transmembrane channel-like protein 2 | chr20 | GO:0005216 | Not Cancer Driver | No | 180 | 0.199 | 293 | 44 | 0.15 | 0 |
TMC3 | TMC3 | Q7Z5M5 | Transmembrane channel-like protein 3 | chr15 | GO:0005216 | Not Cancer Driver | No | 176 | 0.16 | 389 | 67 | 0.172 | 0 |
TMC4 | TMC4 | Q7Z404 | Transmembrane channel-like protein 4 | chr19 | GO:0005216 | Not Cancer Driver | No | 100 | 0.14 | 143 | 37 | 0.259 | 0 |
TMC5 | TMC5 | Q6UXY8 | Transmembrane channel-like protein 5 | chr16 | GO:0005216 | Not Cancer Driver | No | 198 | 0.197 | 387 | 93 | 0.24 | 0 |
TMC6 | TMC6 | Q7Z403 | Transmembrane channel-like protein 6 | chr17 | GO:0005216 | Not Cancer Driver | No | 72 | 0.089 | 129 | 9 | 0.07 | 0 |
TMC7_ENST00000304381 | TMC7 | Q7Z402 | Transmembrane channel-like protein 7 | chr16 | GO:0005216 | Not Cancer Driver | No | 116 | 0.16 | 71 | 9 | 0.127 | 0 |
TMC8 | TMC8 | Q8IU68 | Transmembrane channel-like protein 8 | chr17 | GO:0005216 | Not Cancer Driver | No | 61 | 0.084 | 107 | 10 | 0.093 | 0 |
TMEM120A_ENST00000493111 | TMEM120A | Q9BXJ8 | Ion channel TACAN | chr7 | GO:0005216 | Not Cancer Driver | No | 30 | 0.087 | 26 | 0 | 0.0 | 0 |
TMEM120B | TMEM120B | A0PK00 | Transmembrane protein 120B | chr12 | GO:0005216 | Not Cancer Driver | No | 37 | 0.109 | 6 | 1 | 0.167 | 0 |
TMEM150C | TMEM150C | B9EJG8 | Transmembrane protein 150C | chr4 | GO:0005216 | Not Cancer Driver | No | 38 | 0.153 | 0 | 0 | 0.0 | 0 |
TMEM175 | TMEM175 | Q9BSA9 | Endosomal/lysosomal potassium channel TMEM175 | chr4 | GO:0005216 | Not Cancer Driver | No | 77 | 0.153 | 51 | 13 | 0.255 | 0 |
TMEM206_ENST00000261455 | PACC1 | Q9H813 | Proton-activated chloride channel | chr1 | GO:0005216 | Not Cancer Driver | No | 51 | 0.146 | 32 | 5 | 0.156 | 0 |
TMEM63A | TMEM63A | O94886 | CSC1-like protein 1 | chr1 | GO:0005216 | Not Cancer Driver | No | 87 | 0.108 | 36 | 1 | 0.028 | 3 |
TMEM63B | TMEM63B | Q5T3F8 | CSC1-like protein 2 | chr6 | GO:0005216 | Not Cancer Driver | No | 108 | 0.13 | 78 | 12 | 0.154 | 0 |
TMEM63C | TMEM63C | Q9P1W3 | Calcium permeable stress-gated cation channel 1 | chr14 | GO:0005216 | Not Cancer Driver | No | 114 | 0.141 | 84 | 14 | 0.167 | 0 |
TPCN1_ENST00000335509 | TPCN1 | Q9ULQ1 | Two pore channel protein 1 | chr12 | GO:0005216 | Not Cancer Driver | No | 114 | 0.14 | 99 | 18 | 0.182 | 0 |
TPCN2 | TPCN2 | Q8NHX9 | Two pore channel protein 2 | chr11 | GO:0005216 | Not Cancer Driver | No | 73 | 0.097 | 16 | 0 | 0.0 | 0 |
TRPA1 | TRPA1 | O75762 | Transient receptor potential cation channel subfamily A member 1 | chr8 | GO:0005216 | Not Cancer Driver | No | 324 | 0.29 | 62 | 14 | 0.226 | 1 |
TRPC1 | TRPC1 | P48995 | Short transient receptor potential channel 1 | chr3 | GO:0005216 | Not Cancer Driver | No | 143 | 0.18 | 52 | 11 | 0.212 | 0 |
TRPC3_ENST00000264811 | TRPC3 | Q13507 | Short transient receptor potential channel 3 | chr4 | GO:0005216 | Not Cancer Driver | No | 200 | 0.239 | 23 | 2 | 0.087 | 1 |
TRPC4_ENST00000379705 | TRPC4 | Q9UBN4 | Short transient receptor potential channel 4 | chr13 | GO:0005216 | Not Cancer Driver | No | 322 | 0.33 | 195 | 66 | 0.338 | 0 |
TRPC5 | TRPC5 | Q9UL62 | Short transient receptor potential channel 5 | chrX | GO:0005216 | Not Cancer Driver | No | 255 | 0.262 | 148 | 32 | 0.216 | 0 |
TRPC6 | TRPC6 | Q9Y210 | Short transient receptor potential channel 6 | chr11 | GO:0005216 | Not Cancer Driver | No | 202 | 0.217 | 165 | 46 | 0.279 | 10 |
TRPC7 | TRPC7 | Q9HCX4 | Short transient receptor potential channel 7 | chr5 | GO:0005216 | Not Cancer Driver | No | 224 | 0.26 | 106 | 39 | 0.368 | 0 |
TRPM2_ENST00000397928 | TRPM2 | O94759 | Transient receptor potential cation channel subfamily M member 2 | chr21 | GO:0005216 | Not Cancer Driver | No | 286 | 0.19 | 266 | 44 | 0.165 | 0 |
TRPM4 | TRPM4 | Q8TD43 | Transient receptor potential cation channel subfamily M member 4 | chr19 | GO:0005216 | Not Cancer Driver | No | 152 | 0.125 | 149 | 18 | 0.121 | 12 |
TRPM5 | TRPM5 | Q9NZQ8 | Transient receptor potential cation channel subfamily M member 5 | chr11 | GO:0005216 | Not Cancer Driver | No | 123 | 0.106 | 186 | 19 | 0.102 | 0 |
TRPM8 | TRPM8 | Q7Z2W7 | Transient receptor potential cation channel subfamily M member 8 | chr2 | GO:0005216 | Not Cancer Driver | No | 206 | 0.187 | 43 | 11 | 0.256 | 0 |
TRPV1_ENST00000399756 | TRPV1 | Q8NER1 | Transient receptor potential cation channel subfamily V member 1 | chr17 | GO:0005216 | Not Cancer Driver | No | 93 | 0.111 | 155 | 18 | 0.116 | 0 |
TRPV2 | TRPV2 | Q9Y5S1 | Transient receptor potential cation channel subfamily V member 2 | chr17 | GO:0005216 | Not Cancer Driver | No | 105 | 0.137 | 175 | 23 | 0.131 | 0 |
TRPV3_ENST00000576742 | TRPV3 | Q8NET8 | Transient receptor potential cation channel subfamily V member 3 | chr17 | GO:0005216 | Not Cancer Driver | No | 127 | 0.161 | 177 | 36 | 0.203 | 4 |
TRPV4 | TRPV4 | Q9HBA0 | Transient receptor potential cation channel subfamily V member 4 | chr12 | GO:0005216 | Not Cancer Driver | No | 142 | 0.163 | 231 | 34 | 0.147 | 44 |
TRPV5 | TRPV5 | Q9NQA5 | Transient receptor potential cation channel subfamily V member 5 | chr7 | GO:0005216 | Not Cancer Driver | No | 206 | 0.283 | 68 | 14 | 0.206 | 0 |
TRPV6 | TRPV6 | Q9H1D0 | Transient receptor potential cation channel subfamily V member 6 | chr7 | GO:0005216 | Not Cancer Driver | No | 183 | 0.239 | 77 | 20 | 0.26 | 6 |
TSPOAP1 | TSPOAP1 | O95153 | Peripheral-type benzodiazepine receptor-associated protein 1 | chr17 | GO:0005216 | Not Cancer Driver | No | 268 | 0.144 | 1522 | 213 | 0.14 | 0 |
TTYH1_ENST00000376530 | TTYH1 | Q9H313 | Protein tweety homolog 1 | chr19 | GO:0005216 | Not Cancer Driver | No | 56 | 0.124 | 21 | 3 | 0.143 | 0 |
TTYH2 | TTYH2 | Q9BSA4 | Protein tweety homolog 2 | chr17 | GO:0005216 | Not Cancer Driver | No | 63 | 0.118 | 68 | 19 | 0.279 | 0 |
TTYH3 | TTYH3 | Q9C0H2 | Protein tweety homolog 3 | chr7 | GO:0005216 | Not Cancer Driver | No | 48 | 0.092 | 91 | 14 | 0.154 | 0 |
VDAC1_ENST00000395047 | VDAC1 | P21796 | Voltage-dependent anion-selective channel protein 1 | chr5 | GO:0005216 | Not Cancer Driver | No | 38 | 0.134 | 36 | 4 | 0.111 | 0 |
VDAC2_ENST00000543351 | VDAC2 | P45880 | Voltage-dependent anion-selective channel protein 2 | chr10 | GO:0005216 | Not Cancer Driver | No | 35 | 0.119 | 9 | 1 | 0.111 | 0 |
VDAC3_ENST00000022615 | VDAC3 | Q9Y277 | Voltage-dependent anion-selective channel protein 3 | chr8 | GO:0005216 | Not Cancer Driver | No | 24 | 0.085 | 0 | 0 | 0.0 | 0 |
ZACN | ZACN | Q401N2 | Zinc-activated ligand-gated ion channel | chr17 | GO:0005216 | Not Cancer Driver | No | 46 | 0.112 | 48 | 6 | 0.125 | 0 |